Prevention of stent thrombosis: challenges and solutions

References

• SigwartUPuelJMirkovitchVJoffreFKappenbergerLIntravascular stents to prevent occlusion and restenosis after transluminal angioplastyN Engl J Med19873167017062950322
   PubMed Web of Science ®Google Scholar
• CutlipDEWindeckerSMehranRAcademic Research Consortium. Academic Research Consortium clinical end points in coronary stent trials: a case for standardized definitionsCirculation20071152344235117470709
   PubMed Web of Science ®Google Scholar
• CutlipDENakazawaGKrucoffMWAutopsy validation study of the Academic Research Consortium stent thrombosis definitionJACC Cardiovasc Interv2011455455921596329
   PubMed Web of Science ®Google Scholar
• LevineGNBatesERBlankenshipJC2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and InterventionsJ Am Coll Cardiol201158e44e12222070834
   PubMed Web of Science ®Google Scholar
• WenaweserPDaemenJZwahlenMIncidence and correlates of drug-eluting stent thrombosis in routine clinical practice. 4-year results from a large 2-institutional cohort studyJ Am Coll Cardiol2008521134114018804739
   PubMed Web of Science ®Google Scholar
• CookSWindeckerSEarly stent thrombosis: past, present, and futureCirculation200911965765919204315
   PubMed Web of Science ®Google Scholar
• DoyleBRihalCSO’SullivanCJOutcomes of stent thrombosis and restenosis during extended follow-up of patients treated with bare-metal coronary stentsCirculation20071162391239817984377
   PubMed Web of Science ®Google Scholar
• MauriLHsiehWHMassaroJMHoKKD’AgostinoRCutlipDEStent thrombosis in randomized clinical trials of drug-eluting stentsN Engl J Med20073561020102917296821
   PubMed Web of Science ®Google Scholar
• HolmesDRJrKereiakesDJGargSStent thrombosisJ Am Coll Cardiol2010561357136520946992
   PubMed Web of Science ®Google Scholar
• KirtaneAJStoneGWHow to minimize stent thrombosisCirculation20111241283128721911796
   PubMed Web of Science ®Google Scholar
• RobbinsSLKumarVCotranRSRobbins and Cotran Pathologic Basis of Disease8th edPhiladelphia, PA, USASaunders/Elsevier2010
   Google Scholar
• JeongMHOwenWGStaabMEPorcine model of stent thrombosis: platelets are the primary component of acute stent closureCathet Cardiovasc Diagn19963838438722856
   PubMedGoogle Scholar
• GrewePDenekeTMachraouiABarmeyerJMüllerKAcute and chronic tissue response to coronary stent implantation: pathologic findings in human specimenJ Am Coll Cardiol20003515716310636274
   PubMed Web of Science ®Google Scholar
• FinnAVJonerMNakazawaGPathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelializationCirculation20071152435244117438147
   PubMed Web of Science ®Google Scholar
• NakazawaGStent thrombosis of drug eluting stent: pathological perspectiveJ Cardiol201158849121839616
   PubMed Web of Science ®Google Scholar
• NishihiraKYamashitaAIshikawaTHatakeyamaKShibataYAsadaYComposition of thrombi in late drug-eluting stent thrombosis versus de novo acute myocardial infarctionThromb Res201012625425719942261
   PubMed Web of Science ®Google Scholar
• CookSLadichENakazawaGCorrelation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosisCirculation200912039139919620501
   PubMed Web of Science ®Google Scholar
• NakazawaGOtsukaFNakanoMThe pathology of neoatherosclerosis in human coronary implants: bare-metal and drug-eluting stentsJ Am Coll Cardiol2011571314132221376502
   PubMed Web of Science ®Google Scholar
• FinnAVOtsukaFNeoatherosclerosis: a culprit in very late stent thrombosisCirc Cardiovasc Interv201256922338000
   PubMed Web of Science ®Google Scholar
• ByrneRAJonerMKastratiAPolymer coatings and delayed arterial healing following drug-eluting stent implantationMinerva Cardioangiol20095756758419838148
   PubMedGoogle Scholar
• FinnAVNakazawaGJonerMVascular responses to drug eluting stents: importance of delayed healingArterioscler Thromb Vasc Biol2007271500151017510464
   PubMed Web of Science ®Google Scholar
• JohnMCWesselyRKastratiADifferential healing responses in polymer- and nonpolymer-based sirolimus-eluting stentsJACC Cardiovasc Interv2008153554419463356
   PubMed Web of Science ®Google Scholar
• TadaTByrneRASimunovicIRisk of stent thrombosis among bare-metal stents, first-generation drug-eluting stents, and second-generation drug-eluting stents: results from a registry of 18,334 patientsJACC Cardiovasc Interv201361267127424355117
   PubMed Web of Science ®Google Scholar
• StoneGWMosesJWEllisSGSafety and efficacy of sirolimus-and paclitaxel-eluting coronary stentsN Engl J Med2007356998100817296824
   PubMed Web of Science ®Google Scholar
• WilsonGJNkazawaGSchwartzRSComparison of inflammatory response after implantation of sirolimus and paclitaxel-eluting stents in porcine coronary arteriesCirculation200912014114919564562
   PubMed Web of Science ®Google Scholar
• KolandaiveluKSwaminathanRGibsonWJStent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatingsCirculation20111231400140921422389
   PubMed Web of Science ®Google Scholar
• TadaTByrneRADimopoulosAImpact of stent strut thickness on arterial healing after drug-eluting stents implantation assessed by optical coherence tomographyEur Heart J201334Suppl 13935
   Google Scholar
• YinYZhangYZhaoXSafety and efficacy of biodegradable drug-eluting vs bare metal stents: a meta-analysis from randomized trialsPLoS One20149e9964824945816
   PubMedGoogle Scholar
• BangaloreSTokluBAmorosoNBare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysisBMJ2013347f662524212107
   PubMed Web of Science ®Google Scholar
• StefaniniGGHolmesDRJrDrug-eluting coronary-artery stentsN Engl J Med201336825426523323902
   PubMed Web of Science ®Google Scholar
• SerruysPWOrmistonJAOnumaYA bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methodsLancet200937389791019286089
   PubMed Web of Science ®Google Scholar
• DudekDOnumaYOrmistonJAThuesenLMiquel-HebertKSerruysPWFour-year clinical follow-up of the ABSORB everolimus-eluting bioresorbable vascular scaffold in patients with de novo coronary artery disease: the ABSORB trialEuroIntervention201271060106121959320
   PubMed Web of Science ®Google Scholar
• LeonMBBaimDSPopmaJJA clinical trial comparing three anti-thrombotic drug regimens after coronary artery stentingN Engl J Med1998338166516719834303
   PubMedGoogle Scholar
• MehtaSRYusufSPetersRJClopidogrel in Unstable angina to prevent Recurrent Events trial (CURE) InvestigatorsEffects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention. the PCI-CURE studyLancet200135852753311520521
   PubMed Web of Science ®Google Scholar
• WiviottSDBraunwaldEMcCabeCHTRITON-TIMI 38 InvestigatorsPrasugrel versus clopidogrel in patients with acute coronary syndromesN Engl J Med20073572001201517982182
   PubMed Web of Science ®Google Scholar
• WallentinLBeckerRCBudajAPLATO InvestigatorsTicagrelor versus clopidogrel in patients with acute coronary syndromesN Engl J Med20093611045105719717846
   PubMed Web of Science ®Google Scholar
• MatetzkySShenkmanBGuettaVClopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarctionCirculation20041093171317515184279
   PubMed Web of Science ®Google Scholar
• SimonTVerstuyftCMary-KrauseMFrench Registry of Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) InvestigatorsGenetic determinants of response to clopidogrel and cardiovascular eventsN Engl J Med200936036337519106083
   PubMed Web of Science ®Google Scholar
• MegaJCloseSWiviottSCytochrome p-450 polymorphisms and response to clopidogrelN Engl J Med200936035436219106084
   PubMed Web of Science ®Google Scholar
• SteinhublSRBergerPBMannJT3rdCREDO InvestigatorsClopidogrel for the Reduction of Events During Observation. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trialJAMA20022882411242012435254
   PubMed Web of Science ®Google Scholar
• IakovouISchmidtTBonizzoniEIncidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stentsJAMA20052932126213015870416
   PubMed Web of Science ®Google Scholar
• DaemenJWenaweserPTsuchidaKEarly and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort studyLancet200736966767817321312
   PubMed Web of Science ®Google Scholar
• KuchulakantiPKChuWWTorgusonRCorrelates and long-term outcomes of angiographically proven stent thrombosis with sirolimus-and paclitaxel-eluting stentsCirculation20061131108111316490815
   PubMed Web of Science ®Google Scholar
• MauriLKereiakesDJYehRWDAPT Study InvestigatorsTwelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting StentsN Engl J Med20143712155216625399658
   PubMed Web of Science ®Google Scholar
• FujiiKCarlierSGMintzGSStent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound studyJ Am Coll Cardiol20054599599815808753
   PubMed Web of Science ®Google Scholar
• AlfonsoFSuarezAAngiolilloDJFindings of intravascular-ultrasound during acute stent thrombosisHeart2004901455145915547028
   PubMed Web of Science ®Google Scholar
• CutlipDEBaimDSHoKKStent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trialsCirculation20011031967197111306525
   PubMed Web of Science ®Google Scholar
• CookSWenaweserPTogniMIncomplete stent apposition and very late stent thrombosis after drug-eluting stent implantationCirculation20071152426243417485593
   PubMed Web of Science ®Google Scholar
• van WerkumJWHeestermansAAZomerACPredictors of coronary stent thrombosis: the Dutch Stent Thrombosis RegistryJ Am Coll Cardiol2009531399140919371823
   PubMed Web of Science ®Google Scholar
• GonzaloNBarlisPSerruysPWIncomplete stent apposition and delayed tissue coverage are more frequent in drug-eluting stents implanted during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction than in drug-eluting stents implanted for stable/unstable angina: insights from optical coherence tomographyJACC Cardiovasc Interv2009244545219463469
   PubMed Web of Science ®Google Scholar
• OyabuJUedaYOgasawaraNOkadaKHirayamaAKodamaKAngioscopic evaluation of neointima coverage: sirolimus drug-eluting stent versus bare metal stentAm Heart J20061521168117417161071
   PubMed Web of Science ®Google Scholar
• JonerMFinnAVFarbAPathology of drug-eluting stents in humans: delayed healing and late thrombotic riskJ Am Coll Cardiol20064819320216814667
   PubMed Web of Science ®Google Scholar
• KukrejaNOnumaYGarcia-GarciaHMDaemenJvan DomburgRSerruysPWThe risk of stent thrombosis in patients with acute coronary syndromes treated with bare-metal and drug-eluting stentsJACC Cardiovasc Interv2009253454119539258
   PubMed Web of Science ®Google Scholar
• CheneauELeborgneLMintzGSPredictors of subacute stent thrombosis: results of a systematic intravascular ultrasound studyCirculation2003108434712821553
   PubMed Web of Science ®Google Scholar
• MotovskaZKnotJWidimskyPStent thrombosis – risk assessment and preventionCardiovasc Ther201028e92e10020553282
   PubMed Web of Science ®Google Scholar
• de la Torre-HernándezJMAlfonsoFHernándezFESTROFA Study GroupDrug-eluting stent thrombosis: results from the multicenter Spanish registry ESTROFA (Estudio ESpañol sobre TROmbosis de stents FArmacoactivos)J Am Coll Cardiol20085198699018325436
   PubMed Web of Science ®Google Scholar
• OngATHoyeAAokiJThirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantationJ Am Coll Cardiol20054594795315766834
   PubMed Web of Science ®Google Scholar
• WiviottSDBraunwaldEAngiolilloDJTRITON-TIMI 38 InvestigatorsGreater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel – Thrombolysis in Myocardial Infarction 38Circulation20081181626163618757948
   PubMed Web of Science ®Google Scholar
• KimuraTMorimotoTKozumaKComparisons of baseline demographics, clinical presentation, and long-term outcome among patients with early, late, and very late stent thrombosis of sirolimus-eluting stents: observations from the Registry of Stent Thrombosis for Review and Reevaluation. (RESTART)Circulation2010122526120566955
   PubMed Web of Science ®Google Scholar
• DangasGDCaixetaAMehranRHarmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial InvestigatorsFrequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarctionCirculation20111231745175621482968
   PubMed Web of Science ®Google Scholar
• MoriceMCSerruysPWSousaJEA randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularizationN Engl J Med20023461773178012050336
   PubMed Web of Science ®Google Scholar
• HolmesDRJrLeonMBMosesJWAnalysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosisCirculation200410963464014769686
   PubMed Web of Science ®Google Scholar
• WeiszGLeonMBHolmesDRJrFive-year follow-up after sirolimus-eluting stent implantation: results of the SIRIUS (Sirolimus-Eluting Stent in De-Novo Native Coronary Lesions) trialJ Am Coll Cardiol2009531488149719389558
   PubMed Web of Science ®Google Scholar
• StoneGWMideiMNewmanWComparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trialJAMA20082991903191318430909
   PubMed Web of Science ®Google Scholar
• CostaRALanskyAJMintzGSAngiographic results of the first human experience with everolimus-eluting stents for the treatment of coronary lesions (the FUTURE I trial)Am J Cardiol20059511311615619406
   PubMed Web of Science ®Google Scholar
• SerruysPWOngATPiekJJA randomized comparison of a durable polymer everolimus-eluting stent with a bare metal coronary stent: The SPIRIT first trialEuroIntervention20051586519758878
   PubMedGoogle Scholar
• StoneGWRizviANewmanWEverolimus-eluting versus paclitaxel-eluting stents in coronary artery diseaseN Engl J Med20103621663167420445180
   PubMed Web of Science ®Google Scholar
• KedhiEJoesoefKSMcFaddenESecond-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trialLancet201037520120920060578
   PubMed Web of Science ®Google Scholar
• SchampaertECohenEASchluterMThe Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS)J Am Coll Cardiol2004431110111515028375
   PubMed Web of Science ®Google Scholar
• GrubeESilberSHauptmannKETAXUS I. Six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesionsCirculation2003107384212515740
   PubMed Web of Science ®Google Scholar
• SilberSColomboABanningAPFinal 5-year results of the TAXUS II trial: a randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for de novo coronary artery lesionsCirculation20091201498150419786634
   PubMed Web of Science ®Google Scholar
• EllisSGStoneGWCoxDALong-term safety and efficacy with paclitaxel-eluting stents: 5-year final results of the TAXUS IV clinical trial (TAXUS IV-SR: Treatment of de novo coronary disease using a single paclitaxel-eluting stent)JACC Cardiovasc Interv200921248125920129552
   PubMed Web of Science ®Google Scholar
• EllisSGO’ShaughnessyCDMartinSLTAXUS V ISR InvestigatorsTwo-year clinical outcomes after paclitaxel-eluting stent or brachytherapy treatment for bare metal stent restenosis: the TAXUS V ISR trialEur Heart J2008291625163418556716
   PubMed Web of Science ®Google Scholar
• BurzottaFParmaAPristipinoCAngiographic and clinical outcome of invasively managed patients with thrombosed coronary bare metal or drug-eluting stents: the OPTIMIST studyEur Heart J2008293011302118987096
   PubMed Web of Science ®Google Scholar
• AokiJLanskyAJMehranREarly stent thrombosis in patients with acute coronary syndromes treated with drug-eluting and bare metal stents: the Acute Catheterization and Urgent Intervention Triage Strategy trialCirculation200911968769819171852
   PubMed Web of Science ®Google Scholar
• StoneGWLanskyAJPocockSJHORIZONS-AMI Trial InvestigatorsPaclitaxel-eluting stents versus bare-metal stents in acute myocardial infarctionN Engl J Med20093601946195919420364
   PubMed Web of Science ®Google Scholar
• MauriLSilbaughTSGargPDrug-eluting or bare-metal stents for acute myocardial infarctionN Engl J Med20083591330134218815397
   PubMed Web of Science ®Google Scholar
• SarnoGLagerqvistBNilssonJStent thrombosis in new-generation drug-eluting stents in patients with STEMI undergoing primary PCI: a report from SCAARJ Am Coll Cardiol201464162424998123
   PubMed Web of Science ®Google Scholar
• ChieffoABonizzoniEOrlicDIntraprocedural stent thrombosis during implantation of sirolimus-eluting stentsCirculation20041092732273615148281
   PubMed Web of Science ®Google Scholar
• Biondi-ZoccaiGGSangiorgiGMChieffoAValidation of predictors of intraprocedural stent thrombosis in the drug-eluting stent eraAm J Cardiol2005951466146815950573
   PubMed Web of Science ®Google Scholar
• XuYQuXFangWChenHPrevalence, correlation and clinical outcome of intra-procedural stent thrombosis in patients undergoing primary percutaneous coronary intervention for acute coronary syndromeJ Interv Cardiol20132621522023551235
   PubMed Web of Science ®Google Scholar
• BrenerSJCristeaEKirtaneAJIntra-procedural stent thrombosis: a new risk factor for adverse outcomes in patients undergoing percutaneous coronary intervention for acute coronary syndromesJACC Cardiovasc Interv20136364323266233
   PubMed Web of Science ®Google Scholar
• GénéreuxPStoneGWHarringtonRAImpact of intraprocedural stent thrombosis during percutaneous coronary intervention: insights from the CHAMPION PHOENIX trial (clinical trial comparing cangrelor to clopidogrel standard of care therapy in subjects who require percutaneous coronary intervention)J Am Coll Cardiol20146361962924184169
   PubMed Web of Science ®Google Scholar
• NylanderSAsztélyAReversal of ticagrelor-induced inhibition of ADP-induced platelet aggregation by the addition of uninhibited platelets in vitroJ Am Coll Cardiol20136110S6021560216
   Google Scholar
• BonadeiISciattiEVizzardiED’AloiaARaddinoRMetraMNew frontiers in the management of acute coronary syndromes: cangrelor and elinogrelRecent Pat Cardiovasc Drug Discov6102014 Epub ahead of print
   PubMedGoogle Scholar
• SerebruanyVLSibbingDDiNicolantonioJJDyspnea and reversibility of antiplatelet agents: ticagrelor, elinogrel, cangrelor, and beyondCardiology2014127202424192670
   PubMed Web of Science ®Google Scholar
• YangWWangYLaiADiscovery of 4-aryl-7-hydroxyindoline-based p2y1 antagonists as novel antiplatelet agentsJ Med Chem2014576150616424931384
   PubMed Web of Science ®Google Scholar
• Delesque-TouchardNPfliegerAMBonnet-LignonSSAR216471, an alternative to the use of currently available P2Y12 receptor inhibitors?Thromb Res201413469370325064036
   PubMed Web of Science ®Google Scholar
• DangasGDClaessenBEMehranRDevelopment and validation of a stent thrombosis risk score in patients with acute coronary syndromesJACC Cardiovasc Interv201251097110523174632
   PubMed Web of Science ®Google Scholar
• WaksmanRBarbashIMThe appropriate use of risk scoreJACC Cardiovasc Interv201251106110723174633
   PubMed Web of Science ®Google Scholar